Real world efficacy and safety of nintedanib in idiopathic pulmonary fibrosis: A single center, observational study from India.

Deepak Talwar,Deepak Kumar Prajapat,Dhruv Talwar

Lung India : official organ of Indian Chest Society（2022）

引用 1|浏览0

暂无评分

摘要

Our results support the findings from previous studies, that nintedanib leads to annual decline in parameters such as FVC and DLCO and increased 6-MWD. It was found to be well tolerated in the Indian patients with IPF.

查看译文

关键词

Adverse event,diffusing capacity for carbon monoxide,forced vital capacity,idiopathic pulmonary fibrosis,nintedanib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要